Onorach to Attend TB Drug Discovery Conference

15th November 2010

Onorach™ Clinical is pleased to announce that it will be presenting at the TB Drug Discovery Conference in Glasgow, UK, on 22-23 November 2010.

Jan Anderson, Onorach’s clinical / QA operations manager, will be presenting. Professor Christene Leiper, managing director and president, as well as Stephen Leiper, CEO of Onorach Clinical, will also attend the conference.

TBD-UK has invited Onorach Clinical to present at the two-day conference, which will focus on developing potential new projects, forging new partnerships and an agreement on what actions need to be taken to turn these into a reality. Leading scientists and clinical researchers will also present at the conference.

We are delighted to be participating in this conference, which builds on our interest in tuberculosis. In addition to our focus on tuberculosis trials, Onorach will be involved in a number of other multi-centre, pan-European clinical trials covering a wide range of therapeutic areas in 2011.

Onorach Clinical is a clinical trial support company specialising in supporting our clients set up and deliver clinical trials covering Phases I to IV. We are also experienced in clinical trial services for medical devices and cell-based therapeutics.

We are a young, fast-growing company, focused on providing a fresh approach to the industry. We are based in north-east Scotland, but operate globally, offering our clients the same high-level of service anywhere in the world. We pride ourselves on our growing reputation for our pro-active tailored approach in delivering comprehensive and innovative solutions to the challenges faced in clinical trials. To find out more about our clinical trial services, contact us now.

More About This Company